Showing results (71-80 of 283) with videos related to
Sort By:
Pageof 29
British Journal of Cancer|February 1, 1993
Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cellsS M Lee, N Thatcher, M Dougal, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Bioavailability of ifosfamide in patients with bronchial carcinomaT Cerny, J M Margison, N Thatcher, et al.Cancer|September 15, 1980
Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy--changes in serum levels following C parvum, BCG immunizationN Thatcher, K Hashmi, J Chang, et al.Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|October 1, 2003
Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapyM N Harvie, I T Campbell, N Thatcher, et al.British Journal of Cancer|January 1, 1997
Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patientsD C Betticher, J Heighway, N Thatcher, et al.International Journal of Cancer|February 15, 1987
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patientsT Cerny, V Blair, H Anderson, et al.Biomedical Chromatography : BMC|June 1, 1986
A simple quantitative HPLC assay for ifosfamide in biological fluidsJ M Margison, P M Wilkinson, T Cerny, et al.Cancer|September 15, 1982
Intermittent high-dose cyclophosphamide with and without prednisolone: a study of the relationships between toxicity, response and survival in metastatic lung cancerN Thatcher, J Wagstaff, P Wilkinson, et al.Cancer|June 1, 1986
Treatment of metastatic melanoma by 24-hour DTIC infusions and hemibody irradiationN Thatcher, H Anderson, R James, et al.Seminars in Oncology|June 1, 1997
Gemcitabine: symptomatic benefit in advanced non-small cell lung cancerN Thatcher, G Jayson, B Bradley, et al.Pageof 29